Noting that the Centre had financed and facilitated the production of vaccines through concessions or otherwise, the Supreme Court sought clarification on whether it would be accurate to state that private entities had alone borne the risk and cost of manufacture.It noted that as Emergency Use Authorisation had been granted by the Centre to the manufacturers thereby minimizing their risk,...
